CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome
Clinical trial NCT04893486 · COMPLETED
Trial details
- NCT number
- NCT04893486
- Sponsor
- Palvella Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-06
- Primary completion
- 2023-03-13
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.